We provide you with 20 years of free, institutional-grade data for NCNA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NCNA. Explore the full financial landscape of NCNA stock.
| Reported Date | CIK | Ticker | Type |
|---|
NuCana plc(NASDAQ:NCNA) 
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients wit...
Website: http://www.nucana.com
Founded: 1997
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about NCNA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.